KAM
BIIB icon

Krensavage Asset Management’s Biogen BIIB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-108,923
Closed -$16.7M 15
2024
Q4
$16.7M Sell
108,923
-4,579
-4% -$700K 9.85% 4
2024
Q3
$22M Sell
113,502
-10,283
-8% -$1.99M 12.33% 4
2024
Q2
$28.7M Sell
123,785
-10,283
-8% -$2.38M 13.18% 3
2024
Q1
$28.9M Sell
134,068
-26,412
-16% -$5.7M 12.82% 3
2023
Q4
$41.5M Hold
160,480
14.73% 3
2023
Q3
$41.2M Sell
160,480
-16,346
-9% -$4.2M 15.19% 3
2023
Q2
$50.4M Sell
176,826
-300
-0.2% -$85.5K 15.96% 1
2023
Q1
$49.2M Buy
177,126
+122
+0.1% +$33.9K 14.96% 1
2022
Q4
$49M Sell
177,004
-7,644
-4% -$2.12M 15.15% 2
2022
Q3
$49.3M Buy
184,648
+67,400
+57% +$18M 15.7% 1
2022
Q2
$23.9M Buy
117,248
+5,895
+5% +$1.2M 7.9% 8
2022
Q1
$23.5M Buy
111,353
+8,300
+8% +$1.75M 8.08% 8
2021
Q4
$24.7M Sell
103,053
-149
-0.1% -$35.7K 8.58% 8
2021
Q3
$29.2M Buy
103,202
+5,679
+6% +$1.61M 9.16% 7
2021
Q2
$33.8M Sell
97,523
-40,995
-30% -$14.2M 11.46% 6
2021
Q1
$38.8M Buy
138,518
+501
+0.4% +$140K 13.41% 5
2020
Q4
$33.8M Buy
138,017
+854
+0.6% +$209K 9.87% 6
2020
Q3
$38.9M Sell
137,163
-14,257
-9% -$4.04M 12.39% 4
2020
Q2
$40.5M Buy
151,420
+40,649
+37% +$10.9M 11.02% 4
2020
Q1
$35M Buy
110,771
+867
+0.8% +$274K 11.27% 5
2019
Q4
$32.6M Sell
109,904
-66,806
-38% -$19.8M 11.13% 5
2019
Q3
$41.1M Buy
176,710
+154
+0.1% +$35.9K 15.8% 2
2019
Q2
$41.3M Sell
176,556
-3,444
-2% -$805K 13.4% 3
2019
Q1
$42.5M Buy
+180,000
New +$42.5M 11.5% 4